1 study found for:    ARST0921
Show Display Options
Rank Status Study
1 Active, not recruiting Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
Conditions: Adult Rhabdomyosarcoma;   Childhood Alveolar Rhabdomyosarcoma;   Childhood Pleomorphic Rhabdomyosarcoma;   Childhood Rhabdomyosarcoma With Mixed Embryonal and Alveolar Features;   Previously Treated Childhood Rhabdomyosarcoma;   Recurrent Adult Soft Tissue Sarcoma;   Recurrent Childhood Rhabdomyosarcoma
Interventions: Biological: Bevacizumab;   Drug: Cyclophosphamide;   Other: Laboratory Biomarker Analysis;   Drug: Temsirolimus;   Drug: Vinorelbine Tartrate

Indicates status has not been verified in more than two years